---
title: "BMS and Hengrui forge $15.2bn alliance for early-stage drugs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286117895.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-05-12T14:10:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286117895.md)
  - [en](https://longbridge.com/en/news/286117895.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286117895.md)
---

# BMS and Hengrui forge $15.2bn alliance for early-stage drugs

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [RXL.US](https://longbridge.com/en/quote/RXL.US.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [PILL.US](https://longbridge.com/en/quote/PILL.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [<![CDATA[Bristol Myers Squibb, Hengrui Pharma Form $15.2 Billion Strategic Drug Development Collaboration]]>](https://longbridge.com/en/news/286124106.md)
- [BMS’ Sotyktu secures EC approval for psoriatic arthritis](https://longbridge.com/en/news/285906740.md)
- [Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts](https://longbridge.com/en/news/286453944.md)
- [09:24 ETTigerlily Foundation Collaborates with Bristol Myers Squibb to Advance Clinical Trial Access and Equity](https://longbridge.com/en/news/286573689.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)